Pre-market hot trades in US stocks: PicoCELA pre-market down 7.41%; Greenland Tech pre-market up 7.35%

Pre-market Hot Trades in US Stocks PicoCELA, down 7.41% in pre-market trading, has no significant news recently. The trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Greenland Tech is up 7.35% in pre-market trading. Based on recent key news: On January 29, Greenland Technologies announced a public offering at a price of $1.20 per unit, expecting total proceeds of approximately $6.1 million. This move aims to raise funds for working capital and general corporate purposes, leading to stock price fluctuations. Source: Company news On January 28, the quarterly report submitted by the company showed stable financial conditions with no significant changes. Source: Company announcement No other significant news recently. The US stock market has seen increased volatility lately, which needs attention. Top Gainers in Pre-market US Stocks GlucoTrack is up 67.16% in pre-market trading. Based on recent news, On January 29, GlucoTrack Inc. announced that its latest non-invasive blood glucose monitoring device received FDA approval. This news significantly boosted market confidence, driving the stock price up 67.16%. The market prospects for non-invasive blood glucose monitoring devices are broad. Serina Therapeutics is up 47.79% in pre-market trading. Based on recent key news: On January 28, Serina Therapeutics announced that its drug SER-252 for the treatment of advanced Parkinson's disease received IND application approval from the FDA. This news propelled the company's stock price to rise significantly by 47.79% in pre-market trading. Source: Reuters On January 28, the company released relevant announcements through the EDGAR system, further confirming this important progress. Source: Public Technologies On January 29, Benzinga's stock ranking showed that despite the short-term rise in stock price, the overall price trend remains negative. Source: Benzinga The biopharmaceutical industry has recently seen favorable policies, with clear capital inflows. Healthcare Triangle is up 31.82% in pre-market trading. Based on recent key news: On January 28, Healthcare Triangle announced its participation in the upcoming Deal Flow Discovery Conference, showcasing its digital transformation services in the healthcare and life sciences sectors. This move indicates the company's active pursuit of business opportunities, driving the stock price up. On January 28, the company released the latest information through the EDGAR system, emphasizing its leadership position in digital transformation, enhancing market confidence in its future development On January 28th, the technical sentiment signal indicated a sell, but the market's positive response to the company's participation in the conference offset this negative signal, resulting in a rise in stock prices. The trend of digital transformation in the healthcare industry is evident